ESR1 and triple-negative breast carcinoma: Stratification of a breast cancer patient cohort by estrogen receptor (ER) expression revealed that iNOS expression was predictive of poorer survival in ER− patients,41 whereas high iNOS expression was similarly detrimental in a range of triple-negative breast cancer patient cohorts.42